Neurobiology and neuroanatomy of psychiatric symptoms in parkinsonism

F. Fornai, A. Frati, M. Gesi, F. Fulceri, S. Paparelli, A. Falleni, S. Ruggieri

Research output: Contribution to journalArticle

Abstract

The present article aims to review state-of-the-art evidence of altered neurobiology and neuroanatomy underlying psychiatric symptoms in parkinsonism. This issue covers a wide range of symptoms encompassing anxiety, mood disorders, psychosis as well as substance abuse and specific compulsive behaviors. Such a complex nosography makes it impossible to deal with the neurobiology and neuroanatomy of each psychopathological condition per se, unless offering a trivial list of symptoms joined with brief explanations reporting potential causal mechanisms. This approach would only provide a rough synthesis of what previously reported without adding neither novel concepts nor evidence to improve our insight into the neurobiology of parkinsonism as a psychiatric condition. Therefore, the analytical description of each psychiatric symptom associated with parkinsonism will be avoided but it will be referenced instead. In contrast, the present article will focus on the mechanisms why such a class of nonmotor symptoms clusters in parkinsonian patients. In addition, we will seek to establish the relationship between the occurrence of a given psychiatric condition and specific parkinsonian phenotypes. Again, an emphasis will be given to the occurrence of behavioral fluctuations in parkinsonism where both motor and psychiatric symptoms may possess a specific timing. The timing of these fluctuations will be related to the timing of dopamine substitution therapy and involvement of multiple neurotransmitters and brain regions as well. We provide evidence showing that specific parkinsonian phenotypes (and genotypes) possess a widespread neuropathology, which in turn associates to a fairly specific psychopathology. In contrast, other phenotypes (and genotypes) bring to very selective neuronal degeneration where the occurrence of psychiatric symptoms is rare if not absent at all. These clinical pathological phenotypes associate with specific molecular mechanisms in the dynamics of neurobiology of disease.

Original languageEnglish
Pages (from-to)179-191
Number of pages13
JournalArchives Italiennes de Biologie
Volume151
Issue number4
Publication statusPublished - 2013

Fingerprint

Neuroanatomy
Neurobiology
Parkinsonian Disorders
Psychiatry
Phenotype
Genotype
Compulsive Behavior
Anxiety Disorders
Psychopathology
Mood Disorders
Psychotic Disorders
Substance-Related Disorders
Neurotransmitter Agents
Dopamine
Brain

Keywords

  • Locus coeruleus in parkinsonism
  • Monoamine brainstem disorder
  • Non-Dopamine-dependent psychiatric symptoms
  • Psychiatric fluctuations

ASJC Scopus subject areas

  • Medicine(all)
  • Cell Biology
  • Physiology

Cite this

Fornai, F., Frati, A., Gesi, M., Fulceri, F., Paparelli, S., Falleni, A., & Ruggieri, S. (2013). Neurobiology and neuroanatomy of psychiatric symptoms in parkinsonism. Archives Italiennes de Biologie, 151(4), 179-191.

Neurobiology and neuroanatomy of psychiatric symptoms in parkinsonism. / Fornai, F.; Frati, A.; Gesi, M.; Fulceri, F.; Paparelli, S.; Falleni, A.; Ruggieri, S.

In: Archives Italiennes de Biologie, Vol. 151, No. 4, 2013, p. 179-191.

Research output: Contribution to journalArticle

Fornai, F, Frati, A, Gesi, M, Fulceri, F, Paparelli, S, Falleni, A & Ruggieri, S 2013, 'Neurobiology and neuroanatomy of psychiatric symptoms in parkinsonism', Archives Italiennes de Biologie, vol. 151, no. 4, pp. 179-191.
Fornai, F. ; Frati, A. ; Gesi, M. ; Fulceri, F. ; Paparelli, S. ; Falleni, A. ; Ruggieri, S. / Neurobiology and neuroanatomy of psychiatric symptoms in parkinsonism. In: Archives Italiennes de Biologie. 2013 ; Vol. 151, No. 4. pp. 179-191.
@article{e768e7f7abc547058f8354fccaaa37cb,
title = "Neurobiology and neuroanatomy of psychiatric symptoms in parkinsonism",
abstract = "The present article aims to review state-of-the-art evidence of altered neurobiology and neuroanatomy underlying psychiatric symptoms in parkinsonism. This issue covers a wide range of symptoms encompassing anxiety, mood disorders, psychosis as well as substance abuse and specific compulsive behaviors. Such a complex nosography makes it impossible to deal with the neurobiology and neuroanatomy of each psychopathological condition per se, unless offering a trivial list of symptoms joined with brief explanations reporting potential causal mechanisms. This approach would only provide a rough synthesis of what previously reported without adding neither novel concepts nor evidence to improve our insight into the neurobiology of parkinsonism as a psychiatric condition. Therefore, the analytical description of each psychiatric symptom associated with parkinsonism will be avoided but it will be referenced instead. In contrast, the present article will focus on the mechanisms why such a class of nonmotor symptoms clusters in parkinsonian patients. In addition, we will seek to establish the relationship between the occurrence of a given psychiatric condition and specific parkinsonian phenotypes. Again, an emphasis will be given to the occurrence of behavioral fluctuations in parkinsonism where both motor and psychiatric symptoms may possess a specific timing. The timing of these fluctuations will be related to the timing of dopamine substitution therapy and involvement of multiple neurotransmitters and brain regions as well. We provide evidence showing that specific parkinsonian phenotypes (and genotypes) possess a widespread neuropathology, which in turn associates to a fairly specific psychopathology. In contrast, other phenotypes (and genotypes) bring to very selective neuronal degeneration where the occurrence of psychiatric symptoms is rare if not absent at all. These clinical pathological phenotypes associate with specific molecular mechanisms in the dynamics of neurobiology of disease.",
keywords = "Locus coeruleus in parkinsonism, Monoamine brainstem disorder, Non-Dopamine-dependent psychiatric symptoms, Psychiatric fluctuations",
author = "F. Fornai and A. Frati and M. Gesi and F. Fulceri and S. Paparelli and A. Falleni and S. Ruggieri",
year = "2013",
language = "English",
volume = "151",
pages = "179--191",
journal = "Archives Italiennes de Biologie",
issn = "0003-9829",
publisher = "Pisa University Press",
number = "4",

}

TY - JOUR

T1 - Neurobiology and neuroanatomy of psychiatric symptoms in parkinsonism

AU - Fornai, F.

AU - Frati, A.

AU - Gesi, M.

AU - Fulceri, F.

AU - Paparelli, S.

AU - Falleni, A.

AU - Ruggieri, S.

PY - 2013

Y1 - 2013

N2 - The present article aims to review state-of-the-art evidence of altered neurobiology and neuroanatomy underlying psychiatric symptoms in parkinsonism. This issue covers a wide range of symptoms encompassing anxiety, mood disorders, psychosis as well as substance abuse and specific compulsive behaviors. Such a complex nosography makes it impossible to deal with the neurobiology and neuroanatomy of each psychopathological condition per se, unless offering a trivial list of symptoms joined with brief explanations reporting potential causal mechanisms. This approach would only provide a rough synthesis of what previously reported without adding neither novel concepts nor evidence to improve our insight into the neurobiology of parkinsonism as a psychiatric condition. Therefore, the analytical description of each psychiatric symptom associated with parkinsonism will be avoided but it will be referenced instead. In contrast, the present article will focus on the mechanisms why such a class of nonmotor symptoms clusters in parkinsonian patients. In addition, we will seek to establish the relationship between the occurrence of a given psychiatric condition and specific parkinsonian phenotypes. Again, an emphasis will be given to the occurrence of behavioral fluctuations in parkinsonism where both motor and psychiatric symptoms may possess a specific timing. The timing of these fluctuations will be related to the timing of dopamine substitution therapy and involvement of multiple neurotransmitters and brain regions as well. We provide evidence showing that specific parkinsonian phenotypes (and genotypes) possess a widespread neuropathology, which in turn associates to a fairly specific psychopathology. In contrast, other phenotypes (and genotypes) bring to very selective neuronal degeneration where the occurrence of psychiatric symptoms is rare if not absent at all. These clinical pathological phenotypes associate with specific molecular mechanisms in the dynamics of neurobiology of disease.

AB - The present article aims to review state-of-the-art evidence of altered neurobiology and neuroanatomy underlying psychiatric symptoms in parkinsonism. This issue covers a wide range of symptoms encompassing anxiety, mood disorders, psychosis as well as substance abuse and specific compulsive behaviors. Such a complex nosography makes it impossible to deal with the neurobiology and neuroanatomy of each psychopathological condition per se, unless offering a trivial list of symptoms joined with brief explanations reporting potential causal mechanisms. This approach would only provide a rough synthesis of what previously reported without adding neither novel concepts nor evidence to improve our insight into the neurobiology of parkinsonism as a psychiatric condition. Therefore, the analytical description of each psychiatric symptom associated with parkinsonism will be avoided but it will be referenced instead. In contrast, the present article will focus on the mechanisms why such a class of nonmotor symptoms clusters in parkinsonian patients. In addition, we will seek to establish the relationship between the occurrence of a given psychiatric condition and specific parkinsonian phenotypes. Again, an emphasis will be given to the occurrence of behavioral fluctuations in parkinsonism where both motor and psychiatric symptoms may possess a specific timing. The timing of these fluctuations will be related to the timing of dopamine substitution therapy and involvement of multiple neurotransmitters and brain regions as well. We provide evidence showing that specific parkinsonian phenotypes (and genotypes) possess a widespread neuropathology, which in turn associates to a fairly specific psychopathology. In contrast, other phenotypes (and genotypes) bring to very selective neuronal degeneration where the occurrence of psychiatric symptoms is rare if not absent at all. These clinical pathological phenotypes associate with specific molecular mechanisms in the dynamics of neurobiology of disease.

KW - Locus coeruleus in parkinsonism

KW - Monoamine brainstem disorder

KW - Non-Dopamine-dependent psychiatric symptoms

KW - Psychiatric fluctuations

UR - http://www.scopus.com/inward/record.url?scp=84901368025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901368025&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84901368025

VL - 151

SP - 179

EP - 191

JO - Archives Italiennes de Biologie

JF - Archives Italiennes de Biologie

SN - 0003-9829

IS - 4

ER -